CLEVELAND, Oct. 12, 2015 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) will release its third quarter 2015 financial results at approximately 4:00 PM EST on Thursday, November 5, 2015, and host a conference call shortly thereafter at 4:30 PM EST to review the results. Gil Van Bokkelen, Chairman and Chief Executive Officer, and William (B.J.) Lehmann, President and Chief Operating Officer, will host the call as follows:
|Date||November 5, 2015|
|Time||4:30 p.m. (Eastern Time)|
|Telephone access: US and Canada||800-273-1254|
|Telephone access: International||973-638-3440|
|Live webcast||www.athersys.com under Investors section|
A replay will be available for on-demand listening shortly after the completion of the call until 11:59 PM EST on November 19, 2015 at the aforementioned URL, or by dialing 800-585-8367 or 855-859-2056 in the U.S. and Canada, or from abroad 404-537-3406, and entering access code 22710391.
Athersys is an international biotechnology company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life. The Company is developing its MultiStem® cell therapy product, a patented, adult-derived "off-the-shelf" stem cell product, initially for disease indications in the cardiovascular, neurological, inflammatory and immune disease areas, and has several ongoing clinical trials evaluating this potential regenerative medicine product. Athersys has forged strategic partnerships and collaborations with leading pharmaceutical and biotechnology companies, as well as world-renowned research institutions to further develop its platform and products. More information is available at www.athersys.com.
Contact: William (B.J.) Lehmann, J.D. President and Chief Operating Officer Tel: (216) 431-9900 email@example.com